Steven Huynh

[Steven Huynh @StevenH_0]

@Jayson_Parker Do many biotech companies fail when they try to be innovative because they can't target a customer demographic or get investors/stakeholders convinced?

[Steven Huynh @StevenH_0]

@Jayson_Parker For the Bonferroni Correction, does it have to be used when the data is used multiple times with the same test/model even if they're done "separately" (in the case of our tutorial today)

[Steven Huynh @StevenH_0]

@Jayson_Parker When insider trading occurs, who gets in trouble? Does the person who initially spread the information (in our tutorial, the nurse) or the person who accepted it (the stock analyst). Furthermore, if the stock analyst further spreads it, does he get in trouble?

[Steven Huynh @StevenH_0]

@Jayson_Parker Does the use case for the Bonferroni Correction vary depending on the field/type of study?

[Steven Huynh @StevenH_0]

@Jayson_Parker simple question but are you able to sell a patent or change it's ownership?

[Steven Huynh @StevenH_0]

@Jayson_Parker What's the difference between the NDA and BLA (other than that they're small molecules vs. biologics) documents that makes them separate submissions rather than a single overarching document?